论文部分内容阅读
原发性肝细胞癌(简称肝癌)目前尚无有效的治疗手段,五年生存率很低。由于癌肿本身代谢异常或癌组织对机体发生各种影响引起的内分泌或代谢方面的症候群称副癌综合征,在临床诊断及治疗上往往有重要意义。原发性肝细胞癌的副癌综合征中较为常见的是低血糖症,其发病机制尚不完全清楚,探讨其发生机制有利于预防低血糖的发生、延长患者生存期、提高生活质量,同时还有利于探索治疗肿瘤的新途径。现就原发性肝癌伴发低血糖的发病机制做一综述。
Primary hepatocellular carcinoma (referred to as liver cancer) is currently no effective treatment, five-year survival rate is very low. As the cancer itself, metabolic abnormalities or cancer tissue on the body caused by various effects caused by endocrine or metabolic syndrome called vice cancer syndrome, clinical diagnosis and treatment often have important implications. Hypoglycemia is more common in paraneoplastic syndromes of primary hepatocellular carcinoma. The pathogenesis of hypoglycemia is not yet fully understood. To explore its mechanism is conducive to the prevention of hypoglycemia, extend the survival of patients and improve the quality of life, at the same time Also conducive to explore new ways to treat cancer. Now on the primary liver cancer associated with the pathogenesis of hypoglycemia to do a review.